Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the ...

Opthea Limited ( ($AU:OPT) ) has shared an update. Opthea Limited announced plans to host Investor Days in New York and Australia to discuss ...

GA management involves identifying at-risk patients, assessing visual function, and referring for treatment when necessary.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug ...

Do you have blue eyes? We talked to experts to discover curious facts about baby blues, including whether your biological ...

Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are currently covering the firm, MarketBeat ...

The beginning of the new CPD cycle means it is time to prepare a new professional development plan (PDP) and sketch out areas ...